Applications of targeted proteomics in systems biology and translational medicine

Proteomics

Volumn 15, Issue 18, 2015, Pages 3193-3208

  Ebhardt, H Alexander ^a   Root, Alex ^b,c   Sander, Chris ^b   Aebersold, Ruedi ^a,d  

^a ETH ZURICH   (Switzerland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Clinical proteomics; Multiple reaction monitoring; Selected reaction monitoring; Systems biology; Targeted proteomics

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ANTIBODY AFFINITY; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; EUKARYOTIC CELL; HUMAN; KERATINOCYTE; MASS SPECTROMETRY; MULTIPLE REACTION MONITORING; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; REACTION ANALYSIS; REVIEW; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSLATIONAL RESEARCH;

HUMANS; PROTEOMICS; SYSTEMS BIOLOGY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84941737510     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500004     Document Type: Review

References (140)

1. Ideker, T., Krogan, N. J., Differential network biology. Mol. Syst. Biol. 2012, 8, 1-9.
2. Vidal, M., Cusick, M. E., Barabási, A.-L., Interactome networks and human disease. Cell 2011, 144, 986-998.
3. Bensimon, A., Heck, A. J., Aebersold, R., Mass spectrometry-based proteomics and network biology. Annu. Rev. Biochem. 2012, 81, 379-405.
4. Molinelli, E. J., Korkut, A., Wang, W., Miller, M. L. et al., Perturbation biology: inferring signaling networks in cellular systems. PLoS Comput. Biol. 2013, 9, e1003290.
5. Teo, G., Liu, G., Zhang, J., Nesvizhskii, A. I. et al., SAINTexpress: improvements and additional features in significance analysis of interactome software. J. Proteomics 2014, 100, 37-43.
6. Fermin, D., Basrur, V., Yocum, A. K., Nesvizhskii, A. I., Abacus: a computational tool for extracting and pre-processing spectral count data for label-free quantitative proteomic analysis. Proteomics 2011, 11, 1340-1345.
7. DeSchutter, E., Why are computational neuroscience and systems biology so separate? PLoS Comput. Biol. 2008, 4, e1000078.
8. Kiel, C., Ebhardt, H. A., Burnier, J., Portugal, C. et al., Quantification of ErbB network proteins in three cell types using complementary approaches identifies cell-general and cell-type-specific signaling proteins. J. Proteome Res. 2014, 13, 300-313.
9. Chuang, H.-Y., Hofree, M., Ideker, T., A decade of systems biology. Annu. Rev. Cell Dev. Biol. 2010, 26, 721-744.
10. Batchelor, E., Loewer, A., Mock, C., Lahav, G., Stimulus-dependent dynamics of p53 in single cells. Mol. Syst. Biol. 2011, 7, 488.
11. Nilsson, T., Mann, M., Aebersold, R., Yates, J. R., 3rd et al., Mass spectrometry in high-throughput proteomics: ready for the big time. Nat. Methods 2010, 7, 681-685.
12. Marks, D. S., Colwell, L. J., Sheridan, R., Hopf, T. A. et al., Protein 3D structure computed from evolutionary sequence variation. PLoS ONE 2011, 6, e28766.
13. Vickaryous, M. K., Hall, B. K., Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest. Biol. Rev. Camb. Philos. Soc. 2006, 81, 425-455.
14. Ebhardt, H. A., Sabidó, E., Hüttenhain, R., Collins, B., Aebersold, R., Range of protein detection by selected/multiple reaction monitoring mass spectrometry in an unfractionated human cell culture lysate. Proteomics 2012, 12, 1185-1193.
15. Omenn, G. S., Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins. Biochim. Biophys. Acta 2014, 1844, 866-873.
16. Picotti, P., Bodenmiller, B., Mueller, L. N., Domon, B., Aebersold, R., Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 2009, 138, 795-806.
17. Farkash-Amar, S., Eden, E., Cohen, A., Geva-Zatorsky, N. et al., Dynamic proteomics of human protein level and localization across the cell cycle. PLoS ONE 2012, 7, e48722.
18. Prabakaran, S., Lippens, G., Steen, H., Gunawardena, J., Post-translational modification: nature's escape from genetic imprisonment and the basis for dynamic information encoding. Wiley Interdiscip. Rev. Syst. Biol. Med. 2012, 4, 565-583.
19. Aebersold, R., Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
20. Carlson, S. M., White, F. M., Expanding applications of chemical genetics in signal transduction. Cell Cycle 2012, 11, 1903-1909.
21. Gajadhar, A. S., White, F. M., System level dynamics of post-translational modifications. Curr. Opin. Biotechnol. 2014, 28C, 83-87.
22. Hart, Y., Alon, U., The utility of paradoxical components in biological circuits. Mol. Cell 2013, 49, 213-221.
23. Merbl, Y., Refour, P., Patel, H., Springer, M., Kirschner, M. W., Profiling of ubiquitin-like modifications reveals features of mitotic control. Cell 2013, 152, 1160-1172.
24. Newman, J. R. S., Ghaemmaghami, S., Ihmels, J., Breslow, D. K. et al., Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise. Nature 2006, 441, 840-846.
25. Purvis, J. E., Lahav, G., Encoding and decoding cellular information through signaling dynamics. Cell 2013, 152, 945-956.
26. Khersonsky, O., Tawfik, D. S., Enzyme promiscuity: a mechanistic and evolutionary perspective. Annu.Rev. Biochem. 2010, 79, 471-505.
27. Liu, P., Begley, M., Michowski, W., Inuzuka, H. et al., Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 2014, 508, 541-545.
28. Leng, S. X., McElhaney, J. E., Walston, J. D., Xie, D. et al., ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. 2008, 63, 879-884.
29. Kennedy, J. J., Abbatiello, S. E., Kim, K., Yan, P. et al., Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Nat. Methods 2014, 11, 149-155.
30. Kuhn, E., Whiteaker, J. R., Mani, D. R., Jackson, A. M. et al., Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol. Cell. Proteomics 2012, 11, M111.013854.
31. Wu, Y., Williams, E. G., Dubuis, S., Mottis, A. et al., Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population. Cell 2014, 158, 1415-1430.
32. Picotti, P., Clement-Ziza, M., Lam, H., Campbell, D. S. et al., A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis. Nature 2013, 494, 266-270.
33. Stergachis, A. B., MacLean, B., Lee, K., Stamatoyannopoulos, J. A., MacCoss, M. J., Rapid empirical discovery of optimal peptides for targeted proteomics. Nat. Methods 2011, 8, 1041-1043.
34. Gillette, M. A., Carr, S. A., Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat. Methods 2013, 10, 28-34.
35. Liebler, D. C., Zimmerman, L. J., Targeted quantitation of proteins by mass spectrometry. Biochemistry 2013, 52, 3797-3806.
36. Picotti, P., Aebersold, R., Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Methods 2012, 9, 555-566.
37. Carr, S. A., Abbatiello, S. E., Ackermann, B. L., Borchers, C. et al., Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol. Cell. Proteomics 2014, 13, 907-917.
38. Desiderio, D. M., Kai, M., Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue. Biomed. Mass Spectrom. 1983, 10, 471-479.
39. Ebhardt, H. A., Selected reaction monitoring mass spectrometry: a methodology overview. Methods Mol. Biol. 2014, 1072, 209-222.
40. Worboys, J. D., Sinclair, J., Yuan, Y., Jorgensen, C., Systematic evaluation of quantotypic peptides for targeted analysis of the human kinome. Nat. Methods 2014, 11, 1041-1044.
41. Barnidge, D. R., Dratz, E. A., Martin, T., Bonilla, L. E. et al., Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem. 2003, 75, 445-451.
42. Zhang, F., Bartels, M. J., Stott, W. T., Quantitation of human glutathione S-transferases in complex matrices by liquid chromatography/tandem mass spectrometry with signature peptides. Rapid Commun. Mass Spectrom. 2004, 18, 491-498.
43. Heikkinen, A. T., Friedlein, A., Matondo, M., Hatley, O. J. et al., Quantitative ADME Proteomics - CYP and UGT Enzymes in the Beagle Dog Liver and Intestine. Pharm.Res. 2015, 32, 74-90.
44. Betke, K. M., Rose, K. L., Friedman, D. B., Baucum, A. J., 2nd et al., Differential localization of G protein betagamma subunits. Biochemistry 2014, 53, 2329-2343.
45. Hersman, E. M., Bumpus, N. N., A targeted proteomics approach for profiling murine cytochrome P450 expression. J. Pharm. Exp. Ther. 2014, 349, 221-228.
46. Lange, V., Malmstrom, J. A., Didion, J., King, N. L. et al., Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol. Cell. Proteomics 2008, 7, 1489-1500.
47. Schubert, O. T., Mouritsen, J., Ludwig, C., Rost, H. L. et al., The Mtb proteome library: a resource of assays to quantify the complete proteome of Mycobacterium tuberculosis. Cell Host Microbe 2013, 13, 602-612.
48. Chen, C., Liu, X., Zheng, W., Zhang, L. et al., Screening of missing proteins in the human liver proteome by improved MRM-approach-based targeted proteomics. J. Proteome Res. 2014, 13, 1969-1978.
49. Groh, K. J., Schönenberger, R., Eggen, R. I. L., Segner, H., Suter, M. J.-F., Analysis of protein expression in zebrafish during gonad differentiation by targeted proteomics. Gen. Comp. Endocrinol. 2013, 193, 210-220.
50. Zulak, K. G., Lippert, D. N., Kuzyk, M. A., Domański, D. et al., Targeted proteomics using selected reaction monitoring reveals the induction of specific terpene synthases in a multi-level study of methyl jasmonate-treated Norway spruce (Picea abies). Plant J. 2009, 60, 1015-1030.
51. Choi, S., Kim, J., Yea, K., Suh, P. G. et al., Targeted label-free quantitative analysis of secretory proteins from adipocytes in response to oxidative stress. Anal. Biochem. 2010, 401, 196-202.
52. Bisson, N., James, D. A., Ivosev, G., Tate, S. A. et al., Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat. Biotechnol. 2011, 29, 653-658.
53. Xiang, Y., Remily-Wood, E. R., Oliveira, V., Yarde, D. et al., Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma. Mol. Cell. Proteomics 2011, 10, M110.005520.
54. Sabido, E., Wu, Y., Bautista, L., Porstmann, T. et al., Targeted proteomics reveals strain-specific changes in the mouse insulin and central metabolic pathways after a sustained high-fat diet. Mol. Syst. Biol. 2013, 9, 681-681.
55. Schmidt, C., Lenz, C., Grote, M., Lührmann, R., Urlaub, H., Determination of protein stoichiometry within protein complexes using absolute quantification and multiple reaction monitoring. Anal. Chem. 2010, 82, 2784-2796.
56. Bisetto, E., Comelli, M., Salzano, A. M., Picotti, P. et al., Proteomic analysis of F1F0-ATP synthase super-assembly in mitochondria of cardiomyoblasts undergoing differentiation to the cardiac lineage. Biochim. Biophys. Acta 2013, 1827, 807-816.
57. Ori, A., Andres-Pons, A., Beck, M., The use of targeted proteomics to determine the stoichiometry of large macromolecular assemblies. Methods Cell Biol. 2014, 122, 117-146.
58. Ori, A., Banterle, N., Iskar, M., Andres-Pons, A. et al., Cell type-specific nuclear pores: a case in point for context-dependent stoichiometry of molecular machines. Mol. Syst. Biol. 2013, 9, 648.
59. Soste, M., Hrabakova, R., Wanka, S., Melnik, A. et al., A sentinel protein assay for simultaneously quantifying cellular processes. Nat. Methods 2014, 11, 1045-1048.
60. Glinski, M., Differential multisite phosphorylation of the trehalose-6-phosphate synthase gene family in Arabidopsis thaliana: a mass spectrometry-based process for multiparallel peptide library phosphorylation analysis. Mol. Cell. Proteomics 2005, 4, 1614-1625.
61. Chen, V. C., Gouw, J. W., Naus, C. C., Foster, L. J., Connexin multi-site phosphorylation: mass spectrometry-based proteomics fills the gap. Biochim. Biophys. Acta 2013, 1828, 23-34.
62. Danielson, S. R., Held, J. M., Schilling, B., Oo, M. et al., Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease. Anal. Chem. 2009, 81, 7823-7828.
63. Held, J. M., Danielson, S. R., Behring, J. B., Atsriku, C. et al., Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approach. Mol. Cell. Proteomics 2010, 9, 1400-1410.
64. Huang, F., Zeng, X., Kim, W., Balasubramani, M. et al., Lysine 63-linked polyubiquitination is required for EGF receptor degradation. Proc. Natl. Acad. Sci. 2013, 110, 15722-15727.
65. Darwanto, A., Curtis, M. P., Schrag, M., Kirsch, W. et al., A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation. J. Biol. Chem. 2010, 285, 21868-21876.
66. Wolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., White, F. M., Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. USA 2007, 104, 5860-5865.
67. Rardin, M. J., Held, J. M., Gibson, B. W., Targeted quantitation of acetylated lysine peptides by selected reaction monitoring mass spectrometry. Methods Mol. Biol. 2013, 1077, 121-131.
68. Meo, A. D., Diamandis, E. P., Rodriguez, H., Hoofnagle, A. N. et al., What is wrong with clinical proteomics? Clin. Chem. 2014, 60, 1258-1266.
69. Grebe, S. K., Singh, R. J., LC-MS/MS in the clinical laboratory - where to from here? Clin. Biochem. Rev. 2011, 32, 5-31.
70. Lawson, A. M., The scope of mass spectrometry in clinical chemistry. Clin. Chem. 1975, 21, 803-824.
71. Paulovich, A. G., Whiteaker, J. R., Hoofnagle, A. N., Wang, P., The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline. Proteomics Clin. Appl. 2008, 2, 1386-1402.
72. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.
73. Ioannidis, J. P. A., Biomarker Failures. Clin. Chem. 2013, 59, 202-204.
74. Abbatiello, S. E., Schilling, B., Mani, D. R., Zimmerman, L. J. et al., Large-scale inter-laboratory study to develop, analytically validate and apply highly multiplexed, quantitative peptide assays to measure cancer-relevant proteins in plasma. Mol. Cell. Proteomics 2015, DOI 10.1074/mcp.M114.047050.
75. Cima, I., Schiess, R., Wild, P., Kaelin, M. et al., Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. U S A 2011, 108, 3342-3347.
76. Farrah, T., Deutsch, E. W., Kreisberg, R., Sun, Z. et al., PASSEL: The PeptideAtlas SRMexperiment library. Proteomics 2012, 12, 1170-1175.
77. Ellis, M. J., Gillette, M., Carr, S. A., Paulovich, A. G. et al., Connecting genomic alterations to cancer biology with proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discov. 2013, 3, 1108-1112.
78. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J. et al., Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27, 633-641.
79. Cox, H. D., Lopes, F., Woldemariam, G. A., Becker, J. O. et al., Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry. Clin. Chem. 2014, 60, 541-548.
80. Kuhn, E., Wu, J., Karl, J., Liao, H. et al., Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
81. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
82. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., Carr, S. A., Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2007, 6, 2212-2229.
83. Fortin, T., Salvador, A., Charrier, J. P., Lenz, C. et al., Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol. Cell. Proteomics 2009, 8, 1006-1015.
84. Shi, T., Fillmore, T. L., Sun, X., Zhao, R. et al., Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc. Natl. Acad. Sci. 2012, 109, 15395-15400.
85. Shi, T., Gao, Y., Quek, S. I., Fillmore, T. L. et al., A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum. J. Proteome Res. 2014, 13, 875-882.
86. Fallon, J. K., Neubert, H., Hyland, R., Goosen, T. C., Smith, P. C., Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC-MS/MS with selected reaction monitoring. J. Proteome Res. 2013, 12, 4402-4413.
87. Zhao, Y., Jia, W., Sun, W., Jin, W. et al., Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer. J. Proteome Res. 2010, 9, 3319-3327.
88. Martínez-Morillo, E., Nielsen, H. M., Batruch, I., Drabovich, A. P. et al., Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms. J. Proteome Res. 2014, 13, 1077-1087.
89. Tang, H.-Y., Beer, L. A., Barnhart, K. T., Speicher, D. W., Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring. J. Proteome Res. 2011, 10, 4005-4017.
90. Tian, Y., Zhou, Y., Elliott, S., Aebersold, R., Zhang, H., Solid-phase extraction of N-linked glycopeptides. Nat. Protoc. 2007, 2, 334-339.
91. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
92. Ossola, R., Schiess, R., Picotti, P., Rinner, O. et al., Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites. Methods Mol. Biol. 2011, 728, 179-194.
93. Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K. et al., High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell Proteomics 2007, 6, 1809-1817.
94. Zawadzka, A. M., Schilling, B., Held, J. M., Sahu, A. K. et al., Variation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring (MRM) and SWATH MS2 data-independent acquisition. Electrophoresis 2014, 35, 3487-3497.
95. Huttenhain, R., Surinova, S., Ossola, R., Sun, Z. et al., N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications. Mol. Cell. Proteomics 2013, 12, 1005-1016.
96. Liu, Y., Chen, J., Sethi, A., Li, Q. K. et al., Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol. Cell. Proteomics 2014, 13, 1753-1768.
97. Mause, S. F., Weber, C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 2010, 107, 1047-1057.
98. Smalley, D. M., Ley, K., Plasma-derived microparticles for biomarker discovery. Clin. Lab. 2008, 54, 67-79.
99. Chen, C. L., Lai, Y. F., Tang, P., Chien, K. Y. et al., Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J. Proteome Res. 2012, 11, 5611-5629.
100. Zubiri, I., Posada-Ayala, M., Sanz-Maroto, A., Calvo, E. et al., Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J. Proteomics 2014, 96, 92-102.
101. Kruh-Garcia, N. A., Wolfe, L. M., Chaisson, L. H., Worodria, W. O. et al., Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. PLoS One 2014, 9, e103811.
102. Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B. et al., Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res. 2004, 3, 235-244.
103. Dupuis, A., Hennekinne, J.-A., Garin, J., Brun, V., Protein standard absolute quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks. Proteomics 2008, 8, 4633-4636.
104. Oe, T., Ackermann, B. L., Inoue, K., Berna, M. J. et al., Quantitative analysis of amyloidβ peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20, 3723-3735.
105. Berna, M. J., Zhen, Y., Watson, D. E., Hale, J. E., Ackermann, B. L., strategic use of immunoprecipitation and lc/ms/ms for trace-level protein quantification: myosin light Chain 1, a Biomarker of Cardiac Necrosis. Anal. Chem. 2007, 79, 4199-4205.
106. Nicol, G. R., Han, M., Kim, J., Birse, C. E. et al., Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol. Cell. Proteomics 2008, 7, 1974-1982.
107. Hoofnagle, A. N., Becker, J. O., Wener, M. H., Heinecke, J. W., Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin. Chem. 2008, 54, 1796-1804.
108. Ahn, Y. H., Lee, J. Y., Lee, J. Y., Kim, Y.-S. et al., Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. J. Proteome Res. 2009, 8, 4216-4224.
109. Neubert, H., Gale, J., Muirhead, D., Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen. Clin. Chem. 2010, 56, 1413-1423.
110. Neubert, H., Muirhead, D., Kabir, M., Grace, C. et al., Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor. Anal. Chem. 2013, 85, 1719-1726.
111. Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Abraham, D. et al., Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin. Chem. 2013, 59, 982-990.
112. Krastins, B., Prakash, A., Sarracino, D. A., Nedelkov, D. et al., Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum. Clin. Biochem. 2013, 46, 399-410.
113. Peterman, S., Niederkofler, E. E., Phillips, D. A., Krastins, B. et al., An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM). Proteomics 2014, 14, 1445-1156.
114. Whiteaker, J. R., Zhao, L., Frisch, C., Ylera, F. et al., High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays. J. Proteome Res. 2014, 13, 2187-2196.
115. Schoenherr, R. M., Saul, R. G., Whiteaker, J. R., Yan, P. et al., Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Mol. Cell. Proteomics 2015, 14, 382-398.
116. Kuzyk, M. A., Smith, D., Yang, J., Cross, T. J. et al., Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 2009, 8, 1860-1877.
117. Keshishian, H., Addona, T., Burgess, M., Mani, D. R. et al., Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2009, 8, 2339-2349.
118. Addona, T. A., Shi, X., Keshishian, H., Mani, D. R. et al., A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol. 2011, 29, 635-643.
119. Huillet, C., Adrait, A., Lebert, D., Picard, G. et al., Accurate quantification of cardiovascular biomarkers in serum using protein standard absolute quantification (PSAQ™) and selected reaction monitoring. Mol. Cell. Proteomics 2012, 11, M111.008235.
120. Domański, D., Percy, A. J., Yang, J., Chambers, A. G. et al., MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics 2012, 12, 1222-1243.
121. Yang, S., Chen, L., Sun, S., Shah, P. et al., Glycoproteins identified from heart failure and treatment models. Proteomics 2014, 15, 567-579.
122. DeSouza, L. V., Taylor, A. M., Li, W., Minkoff, M. S. et al., Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J. Proteome Res. 2008, 7, 3525-3534.
123. Chen, Y., Gruidl, M., Remily-Wood, E., Liu, R. Z. et al., Quantification of β-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry. J. Proteome Res. 2010, 9, 4215-4227.
124. Elschenbroich, S., Ignatchenko, V., Clarke, B., Kalloger, S. E. et al., In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. J. Proteome Res. 2011, 10, 2286-2299.
125. Remily-Wood, E. R., Liu, R. Z., Xiang, Y., Chen, Y. et al., A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer. Proteomics Clin. Appl. 2011, 5, 383-396.
126. Selevsek, N., Matondo, M., Carbayo, M. S., Aebersold, R., Domon, B., Systematic quantification of peptides/proteins in urine using selected reaction monitoring. Proteomics 2011, 11, 1135-1147.
127. Wang, Q., Chaerkady, R., Wu, J., Hwang, H. J. et al., Mutant proteins as cancer-specific biomarkers. Proc. Natl. Acad. Sci. 2011, 108, 2444-2449.
128. He, J., Sun, X., Shi, T., Schepmoes, A. A., Fillmore, T. L., Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer. Mol. Oncol. 2014, 8, 1169-1180.
129. Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L. et al., A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 2011, 29, 625-634.
130. Hüttenhain, R., Soste, M., Selevsek, N., Röst, H. et al., Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 2012, 4, 142ra194.
131. Kälin, M., Cima, I., Schiess, R., Fankhauser, N. et al., Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the Pten conditional knockout mouse proteome. Eur. Urol. 2011, 60, 1235-1243.
132. Cerciello, F., Choi, M., Nicastri, A., Bausch-Fluck, D. et al., Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clin. Proteomics 2013, 10, 16.
133. Sprung, R. W., Martinez, M. A., Carpenter, K. L., Ham, A.-J. L. et al., Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue. J. Proteome Res. 2012, 11, 3498-3505.
134. Takadate, T., Onogawa, T., Fukuda, T., Motoi, F. et al., Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues. Int. J. Cancer 2012, 132, 1368-1382.
135. Pan, S., Chen, R., Brand, R. E., Hawley, S. et al., Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J. Proteome Res. 2012, 11, 1937-1948.
136. Lesur, A., Ancheva, L., Kim, Y. J., Berchem, G. et al., Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC-MS in PRM mode. Proteomics Clin. Appl. 2015, DOI 10.1002/prca.201400158.
137. Bruderer, R., Bernhardt, O. M., Gandhi, T., Miladinovic, S. M. et al., Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen treated 3D liver microtissues. Mol. Cell. Proteomics 2015, 14, 1400-1410.
138. Gallien, S., Kim, S. Y., Domon, B., Large-scale targeted proteomics using internal standard triggered-parallel reaction monitoring. Mol. Cell. Proteomics 2015, 14, 1630-1644.
139. Gillet, L. C., Navarro, P., Tate, S., Rost, H. et al., Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 2012, 11, O111 016717.
140. Liu, Y., Buil, A., Collins, B. C., Gillet, L. C. et al., Quantitative variability of 342 plasma proteins in a human twin population. Mol. Syst. Biol. 2015, 11, 786.